25 November 2015 – AGM statement
The company has confirmed that trading continues to be in line with market expectations and the strategic review process announced recently continues according to plan. Continue to BUY.
Regenersis – 185p
25 November 2015 – AGM statement
The company has confirmed that trading continues to be in line with market expectations and the strategic review process announced recently continues according to plan. Continue to BUY.